Analysis of Drug Related Problems (DRPs) of Anti-Tuberculosis Drugs in a Pulmonary Tuberculosis Patient Using the SOAP Method : Analisis Drug Related Problems (DRPs) Obat Anti Tuberkulosis pada Seorang Pasien Tuberkulosis Paru Dengan Metode SOAP

Siti Rouchmana; Safrina Nurjulianti; Jihan Huwaida Noor Santung; Nuraisyah Nuraisyah; Nur Hasanah; Faizah Hanan Lestari; Dinda Hidayah Multazam; Siti Nur Azizah Yahya; Zefany Brilian Siringoringo; Aulia Noor Afifah

doi:10.53342/pharmasci.vi.408

Authors

Siti Rouchmana KBI Farmasi Klinis, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
Safrina Nurjulianti Program Studi Pendidikan Profesi Apoteker, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
Jihan Huwaida Noor Santung Program Studi Pendidikan Profesi Apoteker, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
Nuraisyah Nuraisyah Program Studi Pendidikan Profesi Apoteker, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
Nur Hasanah Program Studi Pendidikan Profesi Apoteker, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
Faizah Hanan Lestari Program Studi Pendidikan Profesi Apoteker, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
Dinda Hidayah Multazam Program Studi Pendidikan Profesi Apoteker, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
Siti Nur Azizah Yahya Program Studi Farmasi, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
Zefany Brilian Siringoringo Program Studi Farmasi, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
Aulia Noor Afifah Program Studi Diploma III, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia

DOI:

https://doi.org/10.53342/pharmasci.vi.408

Keywords:

Tuberculosis, Antituberculosis drug, Drug related problems

Abstract

Tuberculosis is an infectious disease caused by the bacteria Mycobacterium tuberculosis. Drug Related Problem (DRP) is an undesirable event that can occur in a patient that is related to drug use so that it can interfere with achieving the expected therapeutic goals. This research is a study of a 49 year old male patient with a body weight of 45 kg and a height of 154 cm with a diagnosis of pulmonary tuberculosis who received intensive phase anti-tuberculosis drug (OAT) therapy, namely rifampicin, isoniazid, pirazinamide, ethambutol and a continuation phase, namely rifampicin and isoniazid. This study aims to analyze the DRPs of using OAT therapy in a pulmonary tuberculosis patient using the SOAP analysis method. The results of this research are that there are several DRPs that occur and are resolved with suggestions for additional therapy to overcome the side effects felt by patients as well as providing education to patients so that they continue to consume medication regularly.